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Abstract
Context—Tobacco smoking is a recognized behavioral risk factor for periodontal disease
(through its systemic effects), and cannabis smoking may contribute in a similar way.
Objective—To determine whether cannabis smoking is a risk factor for periodontal disease.
Design and Setting—Prospective cohort study of the general population, with cannabis use
determined at ages 18, 21, 26, and 32 years and dental examinations conducted at ages 26 and 32
years. The most recent data collection (at age 32 years) was completed in June 2005.
Participants—A complete birth cohort born in 1972 and 1973 in Dunedin, New Zealand, and
assessed periodically (with a 96% follow-up rate of the 1015 participants who survived to age 32
years). Complete data for this analysis were available from 903 participants (comprising 89.0% of
the surviving birth cohort).
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Main Outcome Measure—Periodontal disease status at age 32 years (and changes from ages
26 to 32 years) determined from periodontal combined attachment loss (CAL) measured at 3 sites
per tooth.
Results—Three cannabis exposure groups were determined: no exposure (293 individuals, or
32.3%), some exposure (428; 47.4%), and high exposure (182; 20.2%). At age 32 years, 265
participants (29.3%) had 1 or more sites with 4 mm or greater CAL, and 111 participants (12.3%)
had 1 or more sites with 5 mm or greater CAL. Incident attachment loss between the ages of 26
and 32 years in the none, some, and high cannabis exposure groups was 6.5%, 11.2%, and 23.6%,
respectively. After controlling for tobacco smoking (measured in pack-years), sex, irregular use of
dental services, and dental plaque, the relative risk estimates for the highest cannabis exposure
group were as follows: 1.6 (95% confidence interval [CI], 1.2–2.2) for having 1 or more sites with
4 mm or greater CAL; 3.1 (95% CI, 1.5–6.4) for having 1 or more sites with 5 mm or greater
CAL; and 2.2 (95% CI, 1.2–3.9) for having incident attachment loss (in comparison with those
who had never smoked cannabis). Tobacco smoking was strongly associated with periodontal
disease experience, but there was no interaction between cannabis use and tobacco smoking in
predicting the condition’s occurrence.
Conclusion—Cannabis smoking may be a risk factor for periodontal disease that is independent
of the use of tobacco.
Periodontal disease (periodontitis) is one of the most common chronic diseases in adults; it
is bacterially mediated inflammation that extends deep into the tissues, causing loss of
supporting connective tissue and alveolar bone.1 Left unchecked in susceptible individuals,
it can result in the loosening and eventual loss of teeth. It is second only to dental caries as a
cause of tooth loss among adults in developed countries.2 Tobacco smoking is recognized as
the primary behavioral risk factor for the condition.3,4 Its effect on the periodontium occurs
systemically through the adverse effects of nicotine and other toxic constituents on immune
function and the inflammatory response, as well as through reducing peripheral blood flow.5
Tobacco smoking has been estimated to contribute at least half of the observed variance in
the condition’s occurrence.6,7 Periodontal disease is understood to be a dynamic
phenomenon with cyclical patterns of progression and resolution8 at any given site. Smoking
is thought to tip the balance toward progression by impairing the immune response and
compromising the periodontal tissue’s ability to heal following a period of disease activity.4
Although a high proportion of the remaining variation can be ascribed to genetic differences,
9 some can also be attributed to other environmental contributors. The deeper inhalation and
prolonged contact and absorption time associated with cannabis smoking suggests that it
may also be a likely candidate in the etiology of periodontal disease. Investigating such an
association is challenging because of the confounding potential of concurrent tobacco
smoking.10 Because of its capacity for measuring the relevant exposures without recall bias,
the prospective cohort study may be the most efficacious approach for investigating the
relationship between cannabis smoking and periodontal disease. We investigated the
independent contributions of cannabis smoking and tobacco smoking to periodontal disease
in the context of a prospective cohort study design.
METHODS
The Dunedin Multidisciplinary Health and Development Study is a longitudinal study of a
cohort of children born at the Queen Mary Hospital, Dunedin, New Zealand, between April
1, 1972, and March 31, 1973.11 That institution was Dunedin’s only obstetric hospital. The
sample that formed the basis for the longitudinal study was 1037 children, all assessed
within a month of their third birthdays, and represents 91.0% of consecutive births. The
participants’ families represented the full range of socioeconomic status. Periodic health and
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developmental data collections (including dental examinations) have since been undertaken.
This study uses data collected from participants at ages 18, 21, 26, and 32 years. More than
90% of the cohort self-identified at age 32 years as being of European origin. Ethical
approval was obtained from the Otago ethics committee, and written informed consent was
obtained from each participant. The most recent data collection (at age 32 years) was
completed in June 2005.
Dental examinations conducted at age 26 years included periodontal measurements made in
2 quadrants. Three sites (mesiobuccal, buccal, and distolingual) per tooth were examined,
and gingival recession (the distance in millimeters from the cementoenamel junction to the
gingival margin) and probing depth (the distance from the probe tip to the gingival margin)
were recorded using a National Institute of Dental Research probe. Periodontal
measurements were not conducted on those reporting a history of cardiac valvular anomalies
or rheumatic fever (15 individuals). The combined attachment loss (CAL) for each site was
computed by summing gingival recession and probing depth (third molars were not
included). The dental examinations were repeated 6 years later at age 32 years. The clinical
procedures were identical except that a full-mouth examination was undertaken. For changes
in periodontal attachment over time (based on half-mouth data from both examinations), an
incident case was an individual with 1 or more sites experiencing an increase in CAL of at
least 3 mm.
Measurement of Cannabis Exposure
At ages 18, 21, 26, and 32 years, participants were asked how many times in the previous
year they had used cannabis. The exposure measure used in the current study was the mean
of the usage over those 4 ages (for which Cronbach α was .79); participants were then
assigned to 1 of 3 distributionally based cannabis exposure groups: the no exposure group,
comprising those who reported 0 occasions of cannabis use; the some exposure group (a
mean of 1–40 occasions of cannabis use during the previous year); and the high exposure
group, who were those with a mean of 41 or more occasions of cannabis use during the
previous year (the highest 20%). Although the usual method of smoking cannabis in New
Zealand is not to mix it with tobacco,12 we cannot be absolutely certain that this was the
case for all participants.
Measurement of Tobacco Smoking
The number of pack-years exposure (that is, the number of packs of cigarettes smoked per
day multiplied by the number of years smoked at that rate) was computed from tobacco
usage data collected for the following periods: up to age 18 years; from ages 18 to 21 years;
from ages 21 to 26 years; and from ages 26 to 32 years. If data were not collected from a
participant at an assessment, his or her responses at the next assessment were used and
calculations made retrospectively.
Other Measures
Each participant’s adult socioeconomic status (SES) was measured at age 32 years by
categorizing his or her adult occupation using standard New Zealand occupation-based
indices,13 which employ a 6-interval classification (where, for example, a physician scores 1
and a laborer scores 6). Those with a score of 5 or 6 were categorized as having low SES. To
determine their usual dental service use pattern, participants were asked (at ages 26 and 32
years) whether they usually visited the dentist for a checkup or because of a problem. The
latter response given at both ages identified “episodic users” of dental care. Dental plaque
accumulation at age 32 years was measured using the Simplified Oral Hygiene Index,14
which scores 6 index teeth as 0 for no plaque detectable with an explorer, 1 for plaque
covering not more than the cervical third of the tooth surface, 2 for plaque covering more
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than one-third but not more than two-thirds, or 3 for plaque extending over more than two-
thirds of the exposed tooth surface. The Simplified Oral Hygiene Index score was computed
as the sum of the scores divided by the number of teeth scored.
Statistical Analysis
Bivariate analyses were conducted using SPSS version 14.0 (SPSS Inc, Chicago, Illinois),
and multivariate analyses used Stata version 10.0 (StataCorp, College Station, Texas). The
analysis began with univariate descriptive statistics for the cohort characteristics, periodontal
attachment loss occurrence, and putative risk markers and risk factors. The bivariate analysis
examined (in the following order) putative risk markers and risk factors by the cohort
characteristics, the occurrence of periodontal attachment loss by the cohort characteristics,
and the occurrence of periodontal attachment loss by the putative risk markers and risk
factors. χ2 Tests were used to examine the statistical significance of differences observed
with categorical dependent variables; analysis of variance was used for continuous variables.
The threshold for statistical significance was P<.05. In the multivariate analyses, the GLM
command in Stata was used with a modified Poisson approach to estimate the relative risk
and confidence intervals by using robust error variances. This was used to examine the
association between cannabis exposure and periodontitis prevalence (using 2 case
definitions of different stringency: 1 or more sites with 4 mm or greater CAL, and 1 or more
sites with 5 mm or greater CAL) and incidence while controlling for tobacco smoking
(pack-years), sex, SES, dental service use, and oral cleanliness. Except for cigarette
smoking, those covariates were chosen because they had either been found in earlier studies
to be confounders of the smoking-periodontitis relationship5 or they were associated (P<.05)
with the dependent variables in the bivariate analyses.
The population attributable risk from cannabis smoking between ages 18 and 32 years was
calculated for the incidence of periodontal disease using 2 incident case definitions: the first
used the incidence of new cases of 4 mm or greater CAL between ages 26 and 32 years; the
second used the incidence of new cases of 5 mm or greater CAL between ages 26 and 32
years. For each (19.3% and 10.4%, respectively), we identified those individuals who were
not cases at 26 years but were cases at age 32 years. This differs from the incident case
definition used elsewhere in the article, which reflects current practice in longitudinal
periodontal research. In current practice, because each individual has more than 1 site (in
fact, the mean [SD] number of measured sites at age 32 years was 80 [6] with a range from
27–84), incident cases are identified as those experiencing either (or both) incident disease
(that is, new attachment loss at a site that previously had had none) or progression (that is,
further attachment loss at a site that had already experienced some). The computation of the
population attributable risk (expressed as a percentage) required identifying and using only
the new cases, and it was computed as the number exposed multiplied by the difference
between incidence rates in those exposed and not exposed and then divided by the total
number in the sample multiplied by their incidence rate.
RESULTS
At age 32 years, 1015 of the 1037 original participants (97.9%) were still alive, and
periodontal examination data were available for 915. Cannabis smoking history information
from at least 2 assessments between ages 18 and 32 years was available for 903 (98.7%) of
those individuals, and all subsequent analyses were limited to those 903. A comparison of
the characteristics of those included and the remainder of the baseline cohort is presented in
Table 1. Individuals with low SES were underrepresented among the participants included in
the analyses.
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Men made up just over half of those included in the current analysis (Table 2) as did
individuals with medium SES. One-third of the participants were episodic users of dentistry
at both 26 and 32 years of age.
Membership of the cannabis exposure groups was as follows: there were 293 (32.3%) in the
none group (0 occasions of cannabis use), 428 (47.4%) in the some group (1–40 occasions),
and 182 (20.2%) in the high group (41 or more occasions).
The prevalence of regular cannabis use (defined as at least weekly) more than doubled from
age 18 to age 26 years and then had fallen slightly by age 32 years (Table 2). Cannabis users
were more likely to be male, to occupy positions of low SES, and less likely to make dental
visits. Mean plaque scores at age 32 years were significantly higher among those who used
cannabis frequently at that age than among the other exposure groups (1.02 and 0.72,
respectively; P<.001).
Overall, half of the cohort (451, or 49.9%) had never smoked tobacco; one-third smoked it
at age 32 years (298, or 33.0%), and the remaining 154 (17.1%) were ex-smokers. Data on
cumulative exposure to tobacco smoking are presented in Table 3 by weekly use of cannabis
at each age. At each age, frequent cannabis smokers were more likely to smoke tobacco.
Those who were regular cannabis smokers at all of the assessment ages had the greatest
tobacco exposure.
One or more periodontal sites with 4 mm or greater CAL were observed in 265 participants
(29.3%) at age 32 years (Table 4). Approximately 1 in 8 were identified as cases using the
more stringent case definition of 1 or more sites with 5-mm CAL. A marked sex difference
seen with the less stringent case definition was less apparent with the 5 mm or greater CAL
criterion. There were marked SES gradients in periodontitis prevalence, with low-SES
participants most affected (and those of high SES the least affected). Disease prevalence was
higher among episodic dental service users than those who were not. Cannabis use was
strongly associated with periodontitis prevalence, and the greatest relative differences were
seen with the 5 mm or greater case definition, with the prevalence among the high exposure
group almost 7 times that among the none group. One in 8 participants experienced incident
attachment loss. There were no significant differences by sex or SES, but there were by
dental service use and by cannabis use; the highest incidence was seen in the high exposure
group.
When regression analysis was used to control for the confounding factors of tobacco
smoking exposure, sex, SES, irregular dental service use, and the amount of plaque present
(Table 5), the relative risk of having 1 or more sites with 4 mm or greater CAL for those
who were in the highest cannabis exposure group was 1.61 (95% confidence interval, 1.16–
2.24) (in comparison with those who had never smoked cannabis). When the more stringent
case definition (1 or more sites with 5 mm or greater CAL) was used, it was 3.13 (95%
confidence interval, 1.53–6.38). The regression analyses were repeated with only those who
had never smoked tobacco (and thus without tobacco exposure in the models).
For those in the highest 20% of cannabis exposure, the relative risk estimates were 2.17
(95% confidence interval, 1.17–4.04) for 1 or more sites with 4 mm or greater CAL and 4.55
(95% confidence interval, 1.33–15.64) for 1 or more sites with 5 mm or greater CAL.
Tobacco smoking was also strongly associated with the condition: for each increase by 1
unit in the number of pack-years, the relative risk increased between 4% and 6%, depending
on the dependent variable. However, there was no interaction detected between tobacco
smoking and cannabis use in predicting periodontitis (P values for the interaction terms in
the 3 models were .26, .12, and .80, respectively). An increase by 1.0 in the plaque score
(representing another one-third of the surface of the teeth covered with plaque) was
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associated with a 22% greater relative risk for having 1 or more sites with 4 mm or greater
CAL.
As a validity check, all regression analyses were repeated using the top quartile and then the
highest 10% for cannabis use (with all other variables remaining unchanged), and cannabis
exposure remained a highly significant predictor in each model (data available on request).
In addition, the analyses were repeated using the extent and severity of periodontitis at age
32 years. The former refers to the percentage of measured sites with 4 mm or greater CAL
or 5 mm or greater CAL (2.0% and 0.2%, respectively, of a mean 80 measured sites). The
latter refers to the mean CAL for sites with 2 mm or greater CAL. The extent and severity of
periodontal disease were significantly greater among the heaviest cannabis users (Table 6).
To determine the contribution of the length of exposure to the association, we also repeated
the multivariate analyses using similarly constructed cannabis exposure variables based only
on ages 26 and 32 years, and the relative risks for the highest 20% of cannabis exposure
were 1.49 (95% confidence interval, 1.13–1.97) for 1 or more sites with 4 mm or greater
CAL and 2.42 (95% confidence interval, 1.41–4.13) for 1 or more sites with 5 mm or greater
CAL.
Finally, regression analyses controlling for the confounding factors showed that the relative
risk of developing attachment loss between ages 26 and 32 years was 2.15 for those who
were in the highest cannabis exposure group (Table 5). The population attributable risk for
new cases of 4 mm or greater CAL was 22.6% while that for the more stringent case
definition of 5 mm or greater CAL was 36.0% (meaning that more than one-third of the new
cases between ages 26 and 32 years were attributable to cannabis smoking).
COMMENT
This prospective cohort study set out to determine whether cannabis smoking was a risk
factor for periodontal disease among young adults. We found that, after controlling for
tobacco smoking (the most important behavioral predictor) and other important confounders,
regular exposure to cannabis smoke was strongly associated with the prevalence and
incidence of periodontal attachment loss by age 32 years.
Before considering the findings, it is appropriate to examine the study’s limitations. First, it
is possible that the prevalence of smoking at each age was underreported because of the
reliance on self-reported smoking exposure data. However, a systematic review of the
literature found high levels of concordance between self-report and biological measures of
smoking exposure, particularly where (as in the current study) data are collected
prospectively and interviewer-administered questionnaires are used in data collection.15 This
has been supported by more recent studies.16–18 In any case, nondifferential underreporting
of either cannabis or tobacco smoking would have resulted in more conservative estimates
of the association with periodontal disease, so our findings are unlikely to be spurious.
Second, we measured periodontal attachment loss at only 3 sites per tooth (instead of 6).
This will have led to some underestimation of both prevalence and incidence, but its
magnitude is unknown. However, a recent study of the effect of partial recording protocols
on estimates of periodontal disease prevalence found that the particular 3-site combination
used in the current study was associated with the least misclassification when compared with
estimates from the use of all 6 sites per tooth.19 We were unable to determine whether any
participant had had periodontal surgery by age 32 years (which could possibly have
eliminated periodontal pocketing).
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Among the study’s strengths are the very high follow-up rates in the longitudinal study, the
prospective determination of smoking exposure (and the length of time over which those
exposure data were collected), and the use of data on periodontal disease incidence as well
as prevalence. Moreover, the typical pattern of cannabis use in New Zealand does not
involve mixing it with tobacco, and this is likely to have resulted in a “cleaner” cannabis
exposure variable. The generalizability of the findings to the source population has been
established, and we addressed in an earlier report20 the issue of the degree to which they can
be generalized to similar populations in both New Zealand and the United States;
essentially, the baseline (age 26 years) peridontal estimates from our study were broadly
comparable with those reported from other representative samples in New Zealand and the
United States.
The study’s demonstration of a strong association between cannabis use and periodontitis
experience by age 32 years indicates that long-term smoking of cannabis is detrimental to
the periodontal tissues and that public health measures to reduce the prevalence of cannabis
smoking may have periodontal benefits for the population. To our knowledge, no previous
studies have examined this relationship, so there are no data with which to compare the
findings. Determining whether the association exists in other populations should be a
priority for periodontal epidemiological research. The nature of the biological mechanism
for the observed association is currently unclear. The periodontal effects of tobacco smoke
are thought to occur via the systemic effects of nicotine and other toxic constituents on
immune function and the inflammatory response within the periodontal tissues. Cannabis
contains more than 400 compounds, including more than 60 cannabinoids; the
noncannabinoid constituents are similar to tobacco (except for nicotine), and those have
been reported to carry systemic health risks and have histopathological effects that are
similar to those of tobacco smoke.21,22
Although definitively establishing the periodontal effects of exposure to cannabis smoke
should await confirmation in other populations and settings, health promoters and dental and
medical practitioners should take steps to raise awareness of the strong probability that
regular cannabis users may be doing damage to the tissues that support their teeth.
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Table 1
Comparison of Characteristics at Age 18 Years for Those Included and Not Included
Characteristic at Age 18 Years
No. (%)
P ValueIncluded Not Included
Total 903 (87.1) 134 (12.9)a
Men 461 (51.1) 74 (55.2) .37
Low socioeconomic statusb 175 (19.5) 40 (30.1) .005
Smoked cannabis at least weekly 75 (8.3) 6 (4.5) .12
Tobacco use, mean (SD), pack-years 0.65 (1.13) 0.95 (1.42) .06
a
Twenty-two participants had died by the assessment at age 32 years; of the remaining 112, 57 were assessed at age 32 years but did not provide
dental or periodontal data, and 12 more provided dental data but not cannabis data.
b
Socioeconomic status was measured by categorizing adult occupation using standard New Zealand occupation-based indices, which employ a 6-
interval classification; those with a score of 5 or 6 were categorized as having low socioeconomic status.
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Table 3
Tobacco Smoking by Weekly Cannabis Use at Ages 18 Through 32 Years
Cannabis Used at Least Weekly
Cumulative Tobacco Smoking to That Age,
Mean (SD),Pack-Years
Median Tobacco Smoking to That Age, Pack-Years
(Interquartile Range)
Age 18 years
 No 0.51 (0.96)a 0.00 (0.00–0.68)
 Yes 2.21 (1.57) 2.25 (1.00–3.00)
Age 21 years
 No 1.17 (1.91)a 0.00 (0.00–1.90)
 Yes 3.48 (2.68) 3.05 (1.20–5.50)
Age 26 years
 No 2.43 (3.58)a 0.00 (0.00–4.50)
 Yes 6.34 (4.68) 6.75 (1.60–10.00)
Age 32 years
 No 3.75 (5.60)a 0.00 (0.00–6.85)
 Yes 10.90 (7.37) 12.43 (4.83–16.06)
At any of ages 18, 21, 26, or 32 years
 No 3.06 (5.04)a 0.00 (0.00–4.93)
 Yes 9.48 (7.31) 9.43 (2.84–15.18)
At each of ages 18, 21, 26, or 32 years
 No 4.32 (5.99)a 0.00 (0.00–7.95)
 Yes 15.32 (6.37) 15.98 (13.46–19.81)
a
P < .001.
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Table 4
Periodontitis Prevalence at Age 32 Years and Incidence From Ages 26 to 32 Years by Sociodemographic
Characteristics, Smoking History, and Exposure to Cannabis
No. (%)
Prevalence
1 or More Sites With ≥ mm CAL 1 or More Sites With ≥ 5 mm CAL
Incidence: 1 or More Sites With ≥ 3 mm
New CAL
Sex
 Female 110 (24.9)a 47 (10.6) 50 (11.3)
 Male 155 (33.6) 64 (13.9) 60 (13.0)
 P value .004 .14 .43
Socioeconomic status groupb
 Low 110 (40.9)a 50 (18.6)a 39 (14.5)
 Medium 121 (25.4) 49 (10.3) 57 (11.9)
 High 33 (21.2) 12 (7.7) 14 (9.0)
 P value <.001 .001 .24
Episodic dental service use at ages 26 and 32 years
 No 132 (23.6)a 42 (7.5)a 58 (10.4)a
 Yes 133 (38.8) 69 (20.1) 52 (15.2)
 P value <.001 <.001 .03
Cannabis exposure group
 None 52 (17.7)a 11 (3.8)a 19 (6.5)a
 Some 120 (28.0) 52 (12.1) 48 (11.2)
 Highest 20% 93 (51.1) 48 (26.4) 43 (23.6)
 P value <.001 <.001 <.001
Total 265 (29.3) 111 (12.3) 110 (12.2)




Socioeconomic status was measured by categorizing adult occupation using standard New Zealand occupation-based indices, which employ a 6-
interval classification; those with a score of 5 or 6 were categorized as having low socioeconomic status, scores 3 and 4 denote medium
socioeconomic status, and scores 1 and 2, high socioeconomic status.
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Table 5
Outcome of Multivariate Analyses of Periodontitis Prevalence and Incidence
Relative Risk (95% Confidence Interval)
Prevalence at Age 32 Years
Incidence Between Ages 26 and
32 Years: ≥ 1 Sites With ≥ 3
mm New CAL
≥ 1 Sites With ≥ 4 mm
CAL
≥ 1 Sites With ≥ 5 mm
CAL
Highest 20% of cannabis exposurea 1.61 (1.16–2.24) 3.13 (1.53–6.38) 2.15 (1.20–3.85)
Some cannabis exposure 1.34 (1.01–1.80) 2.50 (1.32–4.72) 1.47 (0.87–2.47)
Pack-years of tobacco use, per pack year 1.04 (1.03–1.06) 1.06 (1.03–1.09) 1.06 (1.03–1.09)
Female 0.89 (0.72–1.09) 1.00 (0.69–1.43) 1.03 (0.71–1.50)
Low socioeconomic statusb 1.23 (0.87–1.74) 1.31 (0.70–2.44) 1.00 (0.54–1.84)
Medium socioeconomic status 0.98 (0.70–1.36) 1.02 (0.56–1.84) 1.07 (0.61–1.87)
Episodic dental service use at ages 26 and 32
years
1.05 (0.84–1.31) 1.51 (1.00–2.28) 0.90 (0.60–1.34)
Plaque score at age 32 years, per unitc 1.22 (1.01–1.46) 0.99 (0.69–1.40) 1.00 (0.69–1.45)
Abbreviation: CAL, combined attachment loss.
a
Reference categories were as follows: cannabis exposure variables: none group; female: male; low or medium socioeconomic status at age 32
years: high socioeconomic status; episodic dental service use at ages 26 and 32 years: routine dental service use.
b
Socioeconomic status was measured by categorizing adult occupation using standard New Zealand occupation-based indices, which employ a 6-
interval classification; those with a score of 5 or 6 were categorized as having low socioeconomic status, scores 3 and 4 denote medium
socioeconomic status, and scores 1 and 2, high socioeconomic status.
c
This is a continuous variable representing the extent of plaque on 6 index teeth (range, 0 to 3).
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Table 6
Extent and Severity of Combined Attachment Loss by Cannabis Exposure Group
Cannabis Exposure Group, %
None Some Highest 20% All Combined, %
Extent of 4 mm or greater CAL
  Mean (SD) 0.9 (4.2) 1.7 (4.5) 4.7 (10.0)a 2.0 (6.1)
  Median (interquartile range) 0.0 (0.0–0.0) 0.0 (0.0–1.2) 1.2 (0.0–4.8) 0.0 (0.0–1.2)
Extent of 5 mm or greater CAL
  Mean (SD) 0.2 (1.9) 0.4 (1.4) 1.5 (5.1)a 0.6 (2.8)
  Median (interquartile range) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–1.2) 0.0 (0.0–0.0)
Severity of CAL
  Mean (SD) 3.1 (0.2) 3.1 (0.2) 3.3 (0.4)a 3.1 (0.3)
  Median (interquartile range) 3.0 (3.0–3.0) 3.0 (3.0–3.2) 3.2 (3.0–3.4) 3.0 (3.0–3.2)
Abbreviation: CAL, combined attachment loss.
a
P < .001; Kruskal-Wallis test.
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